tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Kiora Pharmaceuticals (KPRX)
NASDAQ:KPRX
US Market
KPRX
Kiora Pharmaceuticals
RESEARCH TOOLSreports

Kiora Pharmaceuticals (KPRX) Stock News & Sentiment

Compare
479 Followers
Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
Premium
Ratings
Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
25d ago
KPRX
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
Kiora Pharmaceuticals: Strong Financial Position and Promising Clinical Developments Drive Buy Rating
4M ago
KPRX
Kiora Pharmaceuticals Reports Improved Financial Performance
Premium
Company Announcements
Kiora Pharmaceuticals Reports Improved Financial Performance
4M ago
KPRX
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
Premium
Company Announcements
Kiora Pharmaceuticals Advances Phase II Study for Retinitis Pigmentosa Treatment
5M ago
KPRX
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
Premium
Company Announcements
Kiora Pharmaceuticals Advances Promising Eye Treatment with KIO-301 Study
5M ago
KPRX
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
Premium
Company Announcements
Kiora Pharmaceuticals’ KIO-104: A Promising Treatment for Macular Edema?
5M ago
KPRX
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
Premium
Company Announcements
Kiora Pharmaceuticals Highlights at Ophthalmology Conference
7M ago
8K
KPRX
More KPRX News >

KPRX News on the Web

Clinical and Market Validation of Kiora’s Lead Programs Underpin Buy Rating and $12 Price Target
TipRanks News
Bullish
Kiora Pharmaceuticals granted new patent for KIO-104, says H.C. Wainwright
The Fly
Neutral
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know
Zacks
Bullish
Kiora Pharmaceuticals Reports Q1 2025 Financial Results
TipRanks News
Neutral
Positive Developments and Strategic Partnerships Propel Kiora Pharmaceuticals to a Buy Rating
TipRanks News
Bullish
Kiora Pharmaceuticals target ajusted to $54 from $6 at Ladenburg
The Fly
Neutral
Buy Rating on Kiora Pharmaceuticals: Strong Financials and Promising KIO-301 Progress
TipRanks News
Bullish
Is Kiora Pharmaceuticals (KPRX) Stock Undervalued Right Now?
Zacks
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KPRX’s Media Buzz Sentiment?
Currently, no data Available
What is KPRX’s weekly average amount of articles?
Currently, no data Available
What is KPRX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
KHTRFKnight Therapeutics
HYPRHyperfine
KMTSKestra Medical Technologies Ltd.
OVIDOvid Therapeutics
PYPDPolyPid
Showing the stocks with the most bullish news sentiment over the past week